ArticleCNS neuroscience & therapeutics2026

Tacrolimus as Single-Agent Immunotherapy for Adult-Onset Myasthenia Gravis: Remission, Relapse, and Safety.

Zhangyan Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.